Gibotech A/S Due Diligence

Run due diligence on Gibotech A/S: check compliance and get alerts when suppliers or ownership change.

Denmark · owned by GLORIA FINIS HOLDING ApS (Denmark) · gibotech.dk · 13 vendors

Gibotech A/S is a Danish company headquartered in Odense that develops, installs, and services advanced automation solutions using robots and CNC machines. The company serves both the healthcare sector — including hospitals (sterilization centers, logistics, kitchen automation, laboratory automation, and bed storage) — and industrial clients. Originally founded in 1984 as Giben Scandinavia A/S, the company rebranded to Gibotech in 2009 and has grown to over 115 employees, with a mission to elevate healthcare through innovative and sustainable automation.

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 13 sub-vendors.

Insights

Last updated 2026-10-14 · revision 2

13 direct vendors, 144 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 7/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Gibotech A/S exhibits a moderate to high level of migration readiness. A significant advantage is the explicitly low vendor lock-in risk due to a diverse vendor base (12 vendors, 6+ HQ countries), which would simplify transitioning away from or integrating new solutions. The company's internal tech stack largely consists of SaaS platforms (e.g., Webflow, Google Tag Manager, Mailchimp), meaning these components are already leveraging cloud services and would not require traditional "migration" efforts. The "Modular Automation System Design" and "GiboSmartSolutions" suggest an architectural approach that could facilitate the integration of cloud-based management, monitoring, or data analytics solutions for their industrial automation products. However, the core business involves physical industrial automation (robots, CNC machines, AGVs), which inherently limits the scope of traditional "cloud migration" compared to purely software-based enterprises. Any migration strategy would need to carefully consider the implications of NIS2 applicability, particularly regarding data security and operational continuity. The assessment is constrained by the lack of specified data residency requirements and financial stability data, both of which are crucial for planning and funding migration initiatives.

Compliance

11 in-scope frameworks identified; showing 3.

NIS2 (source) — No public evidence

Gibotech's work in the healthcare sector, providing automation for hospitals, could potentially bring it within the scope of the NIS2 Directive as a supplier to an essential entity. However, its direct applicability would depend on its size and specific services.

LVD — No public evidence

Gibotech's automation solutions and machinery operate within the voltage limits of the Low Voltage Directive (50-1000V AC and 75-1500V DC), making them subject to its safety requirements.

RoHS Directive — No public evidence

As a manufacturer of electrical and electronic equipment, Gibotech is subject to the RoHS Directive, which restricts the use of certain hazardous substances in their products.

Financials

Three-year financials

Financial Resilience Score: 5/10

Gibotech A/S presents a mixed resilience picture. On the positive side, the company has a stable top-line activity base with gross profit holding around DKK 115M for two years before easing ~8% in FY2025, a growing equity cushion (DKK 32.8M in 2022 to DKK 41.5M in 2025), and strong strategic backing as a 100%-owned subsidiary of Sanovo Technology Robotics A/S within the SANOVO TECHNOLOGY GROUP. The 40+ year franchise, patent portfolio in sterile-processing automation, and large installed base support recurring service revenues. However, profitability has deteriorated severely: EBIT fell from DKK 20.3M (2023) to DKK 5.3M (2024) to DKK 1.69M (2025) — a cumulative ~92% decline. On broadly flat gross profit, this points to cost inflation outrunning revenue, with headcount peaking at 179 in 2024 before being cut to 166 in 2025. ROE of ~3.7% in FY2025 is well below cost of capital. The solvency ratio of ~28% at YE2024 is modest, and the recent auditor change (Deloitte to Cedra in September 2026) immediately after a weak year warrants attention. Project-business lumpiness and limited public disclosure add further uncertainty.

Key strengths: Stable gross profit around DKK 115M for 2023-2024, easing to DKK 106M in 2025, Equity growing consistently from DKK 32.8M (2022) to DKK 41.5M (2025), 100% owned by Sanovo Technology Robotics A/S, providing captive internal demand and global sales network access, 40+ year operational history with durable installed base supporting service/aftermarket revenue, Patent portfolio in sterile-processing automation, Solvency ratio ~28% at YE2024

Risk factors: Severe margin compression: EBIT down ~92% cumulatively from 2023 to 2025, Thin profitability vs. equity: ROE only ~3.7% in FY2025, Workforce rightsizing in progress (179 to 166 average employees), Auditor change in September 2026 immediately after weak year, Project-business lumpiness creating large single-contract swings, Limited public disclosure (no turnover line, no segment reporting, no cash flow commentary), Single-site concentration in Denmark

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report